IP Library › Granted Patent US 11,529,337
Granted Patent B2
US 11,529,337 · App. 16/968,983 · Granted Dec 20, 2022

Method of treating pain

Inventors: Sagar Agarwal (Medford, MA); Cynthia Barber (Wayland, MA); Francoise Berlioz-Seux (Lexington, MA); Brenda Cirincione (Newtown, PA); James Jones (Norfolk, MA); Sandra Lechner (San Diego, CA); Marco Rizzo (Guilford, CT); David Stiles (Danvers, MA)
Assignee: Vertex Pharmaceuticals Incorporated
A61K31/4412A61K31/661A61P25/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,529,337
App. No.
16/968,983
Granted
Dec 20, 2022
Kind
B2
Abstract

Provided is a method of treating or lessening the severity of pain in a subject, comprising administering to the subject a compound of formula (I), defined as described herein, or a pharmaceutically acceptable salt thereof.

Claims (14)

1. A method of treating or lessening the severity of pain in a subject, comprising administering to the subject orally a compound of formula (I)

or a pharmaceutically acceptable salt thereof, wherein:

(a) the compound of formula (I), or a pharmaceutically acceptable salt thereof, is administered every 12 hours in a first dose of 1500 mg and a subsequent dose of 750 mg; or

(b) the compound of formula (I), or a pharmaceutically acceptable salt thereof, is administered every 12 hours in a first dose of 500 mg and a subsequent dose of 250 mg.

2. The method of claim 1 , wherein the compound of formula (I), or a pharmaceutically acceptable salt thereof, is administered every 12 hours in a first dose of 1500 mg and a subsequent dose of 750 mg.

3. The method of claim 2 , wherein the pain is acute pain.

4. The method of claim 3 , wherein the acute pain is acute post-operative pain.

5. The method of claim 2 , wherein the pain is postsurgical pain.

6. The method of claim 5 , wherein the postsurgical pain is bunionectomy pain.

7. The method of claim 1 , wherein the compound of formula (I), or a pharmaceutically acceptable salt thereof, is administered every 12 hours in a first dose of 500 mg and a subsequent dose of 250 mg.

8. The method of claim 7 , wherein the pain is acute pain.

9. The method of claim 8 , wherein the acute pain is acute post-operative pain.

10. The method of claim 7 , wherein the pain is postsurgical pain.

11. The method of claim 10 , wherein the postsurgical pain is bunionectomy pain.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 29, 2020
From: BERLIOZ-SEUX, FRANCOISE; CIRINCIONE, BRENDA; JONES, JAMES; STILES, DAVID
To: VERTEX PHARMACEUTICALS INCORPORATED
Reel/Frame 053913/0432 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 29, 2020
From: AGARWAL, SAGAR
To: VERTEX PHARMACEUTICALS INCORPORATED
Reel/Frame 053913/0728 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 29, 2020
From: RIZZO, MARCO
To: VERTEX PHARMACEUTICALS INCORPORATED
Reel/Frame 053913/0868 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 29, 2020
From: BARBER, CYNTHIA
To: VERTEX PHARMACEUTICALS INCORPORATED
Reel/Frame 053914/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 29, 2020
From: LECHNER, SANDRA
To: VERTEX PHARMACEUTICALS (SAN DIEGO) LLC
Reel/Frame 053914/0149 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 29, 2020
From: VERTEX PHARMACEUTICALS (SAN DIEGO) LLC
To: VERTEX PHARMACEUTICALS INCORPORATED
Reel/Frame 053914/0235 →
Continuity (4)
Provisional Application 62780281 · Dec 16, 2018
Provisional Application 62778881 · Dec 12, 2018
Provisional Application 62629308 · Feb 12, 2018
Related Publication 20210052610A1 · Feb 25, 2021
Cited By (4)
US 12,247,021 US 12,258,333 US 12,503,439 US 12,662,470